EndoSound's introduction of a groundbreaking EVS (Endoscopic Visualisation System) innovation marks a significant advancement in the field of endoscopic ultrasound (EUS).
The EVS is an innovative endoscopic ultrasound (EUS) device is designed to seamlessly attach to upper gastrointestinal endoscopes. Its compatibility allows for effortless integration into the existing ecosystem of any endoscopy centre.
The introduction of the EVS is set to transform the landscape of endoscopic ultrasound (EUS). Offering a more cost-effective solution, the EVS has the potential to significantly enhance access to this essential imaging and therapeutic procedure compared to traditional EUS equipment. By doing so, it will redirect care to more efficient settings such as ambulatory surgery centres (ASCs), which are favoured by patients, healthcare providers, and payers alike.
The EVS is poised to not just improve the safety of endoscopic procedures but also facilitate broader access to healthcare for patients globally.
The EVS marks a substantial advancement in medical technology, specifically targeting the crucial problem of infections related to endoscope elevators that are hard to clean. This approval validates the system's effectiveness and safety, highlighting EndoSound's dedication to advancing healthcare through innovative approaches.
Endoscopic Ultrasound (EUS) is a minimally invasive procedure used for diagnosing GI tract and adjacent organ diseases. It employs high-frequency sound waves to create precise images of the pancreas, liver, and gallbladder. Presently, hospitals accommodate over 95 percent of EUS patients. However, many of these cases could be efficiently managed in ambulatory surgery centres (ASCs), aligning with patient preferences for treatment venues.
EndoSound receives 510(k) clearance for first-of-its-kind Endoscopic Ultrasound (EUS) technology.
